Competition stiff for DPP-4 inhibitors
Published: 2012-11-20 06:57:00
Updated: 2012-11-20 06:57:00
Multinational pharmaceutical companies are stepping up their marketing in the dipeptidyl peptidase-4 (DPP-4) inhibitors in Korea, which is forecast to become more competitive than ever early next year, according to industry sources.
The enzyme DPP-4 normally breaks down a peptide, called GLP-...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
